Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US2546041011
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG00W9MJK79
IRON
Disc Medicine Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Disc Medicine Inc
ISIN
US2546041011
TICKER
IRON
MIC
XNAS
REUTERS
IRON.OQ
BLOOMBERG
IRON US
Sa., 20.06.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - June 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Fr., 19.06.2026       Disc Medicine
US2546041011

NEW YORK, June 19, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materiall...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 16.06.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - June 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the inves...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
So., 14.06.2026       Disc Medicine
US2546041011

NEW YORK, June 14, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materiall...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Sa., 13.06.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - June 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Fr., 12.06.2026       Disc Medicine
US2546041011

WATERTOWN, Mass., June 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announces updated data from multiple clinical programs to be presented at...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Fr., 12.06.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - June 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Do., 11.06.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - June 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 09.06.2026       Disc Medicine
US2546041011

WATERTOWN, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced it has completed a Type A meeting with the US Food and Drug Adm...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 09.06.2026       Disc Medicine
US2546041011

NEW YORK, June 8, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Fr., 05.06.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - June 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing p...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Do., 04.06.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - June 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing p...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Do., 04.06.2026       Disc Medicine
US2546041011

NEW YORK, June 3, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 02.06.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - June 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing p...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mo., 01.06.2026       Disc Medicine
US2546041011

WATERTOWN, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the launch of an expanded access program (EAP) for bitopertin f...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mo., 01.06.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing p...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Sa., 30.05.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - May 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing p...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Do., 28.05.2026       Disc Medicine
US2546041011

NEW YORK, May 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegat...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 26.05.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - May 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing p...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mo., 25.05.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - May 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing p...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 18.05.2026       Disc Medicine
US2546041011

NEW YORK, May 18, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegat...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 12.05.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - May 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing p...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 12.05.2026       Disc Medicine
US2546041011

WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from multiple programs in its hematolo...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 12.05.2026       Disc Medicine
US2546041011

NEW YORK, May 11, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegat...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mo., 11.05.2026       Disc Medicine
US2546041011

WATERTOWN, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at tw...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Do., 07.05.2026       Disc Medicine
US2546041011

NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mi., 06.05.2026       Disc Medicine
US2546041011

NEW YORK, May 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegati...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 05.05.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - May 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing pu...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 05.05.2026       Disc Medicine
US2546041011

WATERTOWN, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today reported financial results for the first quarter ended March 31, 2026, and...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mo., 04.05.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - May 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing pu...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Fr., 01.05.2026       Disc Medicine
US2546041011

NEW YORK, April 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.  ...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Fr., 01.05.2026       Disc Medicine
US2546041011

NEW YORK, April 30, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from alleg...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mi., 29.04.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - April 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine, Inc. may have issued materially misleading business information to th...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 28.04.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - April 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mo., 27.04.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - April 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the inve...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Sa., 25.04.2026       Disc Medicine
US2546041011

NEW YORK, April 25, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from alleg...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mi., 22.04.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - April 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 21.04.2026       Disc Medicine
US2546041011

WATERTOWN, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from the RALLY-MF Phase 2 trial of D...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 21.04.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - April 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the inve...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Do., 16.04.2026       Disc Medicine
US2546041011

NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Di., 14.04.2026       Disc Medicine
US2546041011

NEW YORK, April 14, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from alle...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Sa., 11.04.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - April 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Do., 09.04.2026       Disc Medicine
US2546041011

NEW YORK, April 9, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allega...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Do., 09.04.2026       Disc Medicine
US2546041011

NEW YORK, April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mo., 06.04.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. (NASDAQ: IRON) ("Disc Medicine, Inc.") concerning potential violations of the federal securities laws.On February 13, 2026, Disc disclosed that the FDA had issued a Complete Respons...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Do., 02.04.2026       Disc Medicine
US2546041011

NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. ("Disc" or the "Company") (NASDAQ: IRON).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.  ...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mi., 01.04.2026       Disc Medicine
US2546041011

Investigation examines gap between reported figures and GAAP results at Disc Medicine ahead of its 21.9% stock collapse NEW YORK, April 1, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating whether Disc Medicine, Inc. (NASDAQ: IRON) and certain of its officers fulfilled their disclosure obligations to investors in the period leading...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mo., 30.03.2026       Disc Medicine
US2546041011

NEW YORK, March 30, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from alleg...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mo., 30.03.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. ("Disc Medicine, Inc.") (NASDAQ: IRON) concerning potential violations of the federal securities laws.On February 13, 2026, Disc disclosed that the FDA had issued a Complete Response Letter...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink
Mo., 30.03.2026       Disc Medicine
US2546041011

New York, New York--(Newsfile Corp. - March 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the inve...
Zur Nachricht
Disc Medicine
Charts & Research Termsheets Terminal
Permalink